Concord Drugs (BOM:538965) Change In Inventory : ₹0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs Change In Inventory?

Concord Drugs's change in inventory for the quarter that ended in Dec. 2023 was ₹0.0 Mil. It means Concord Drugs's inventory stayed the same from Sep. 2023 to Dec. 2023 .

Concord Drugs's change in inventory for the fiscal year that ended in Mar. 2023 was ₹-6.9 Mil. It means Concord Drugs's inventory increased by ₹6.9 Mil from Mar. 2022 to Mar. 2023 .

Concord Drugs's Total Inventories for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Concord Drugs's Days Inventory for the quarter that ended in Dec. 2023 was 98.88.

Inventory Turnover measures how fast the company turns over its inventory within a year. Concord Drugs's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.92.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Concord Drugs's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.86.

Concord Drugs Change In Inventory Historical Data

The historical data trend for Concord Drugs's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs Change In Inventory Chart

Concord Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Inventory

Get a 7-Day Free Trial

-0.22

22.10

45.59

-56.18

-6.86

Concord Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Concord Drugs Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

Concord Drugs (BOM:538965) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Concord Drugs's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	109.669	/	101.21	*	365 / 4
	=	98.88

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Concord Drugs's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	101.21	/	109.669
	=	0.92

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Concord Drugs's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	109.669	/	127.837
	=	0.86

Concord Drugs Change In Inventory Related Terms

Thank you for viewing the detailed overview of Concord Drugs's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Drugs (BOM:538965) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » Change In Inventory

Traded in Other Exchanges

N/A

Address

3-11-451, L B Nagar, Hayatnagar Mandal, Hyderabad, TG, IND, 500074

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.

Concord Drugs (BOM:538965) Headlines

No Headlines